The mRNA based Therapeutic Summit brings together key opinion leaders from Europe and the rest of the world to delve deep into the challenges associated with successfully designing and developing the next-generation of mRNA-based vaccines & therapeutics with improved specificity, delivery & efficacy for immuno-oncology, infectious diseases and beyond.
Featured Presentation Date: tbd Time: tbd Title: mRNA Modifications that Matter: Modified Uridine as a Therapeutic Tool
Featured Speaker: Alexandre DiPaolo, PhD
Sr. Business Development Manager (Europe), TriLink BioTechnologies
In this presentation, we will explore In vitro transcribed (IVT) mRNA which has become an effective and scalable therapeutic modality for a wide range of disease indications. However, therapeutic efficacy may still be improved by making modifications to the wild-type nucleobase uridine. To aid in the synthesis of therapeutic mRNA, TriLink offers an extensive platform for the manufacturing of modified uridine and mRNA at GMP quality and scale. Schedule a meeting with us
